Hydrochlorothiazide

Hydrochlorothiazide

Products
Hydrochlorothiazide
Hydrochlorothiazide

Information

Hydrochlorothiazide Therapeutic Area: Cardiovascular systemEU DMF availableUS DMF no. 17599 availableJapanese DMF available CEP available Indication: Hydrochlorothiazide is a diuretic drug of the thiazide class that acts by inhibiting the kidneys' ability to retain water. This reduces the volume of the blood, decreasing blood return to the heart and thus cardiac output and, by other mechanisms, is believed to lower peripheral vascular resistance
Distribution Areas
North America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
Supplied From
Poland
Polpharma GroupPolpharma Group is a high quality European pharma manufacturer and a reputable business partner for companies worldwide at every stage of product development, manufacturing & commercialization (FDF, API, CDMO, CMO). Polpharma API is a Poland-based CDMO of APIs, and significant European API producer, delivering products to more than 65 countries on 6 continents. We run with $45-million manufacturing expansion to include HPAPI and cryogenic technologies and investments in a pilot plant and R&D capabilities.

Log in

See all the content and easy-to-use features by logging in or registering!